Shin, Youjung (Author)
In 2012, all the students in South Korea from elementary to high school went through the government’s mental health screening. From a historical perspective, this paper examines why and how the Korean government launched the mass screening of students’ mental health and what enabled this nationwide data collection. By analyzing its driving forces, this paper reveals the ecology of power being forged at the intersection of multinational pharmaceutical companies, mental health experts, and the Korean government in the 2000s. The paper argues that, against the backdrop of the growing market for multinational pharmaceutical companies in South Korea, the rise in school violence became the catalyst for bringing old and new governmental tools, plans, and resources, putting all students under mental health screening. It shows the continuity as well as the transformation of developmental governmentality in a broader social change of South Korea under the influence of globalization. By doing so, the paper illuminates the shaping of the governmental technology – which was developed rather than imported and deployed rather than recommended – that enabled the nationwide collection of students’ data in the context of globalizing and politicizing ideas and practices in mental health.
...More
Article
Jaehwan Hyun;
(2019)
Tracing National Origins, Debating Ethnic Homogeneity: Population Genetics and the Politics of National Identity in South Korea
(/isis/citation/CBB428333857/)
Book
Horace A. Bartilow;
(2019)
Drug War Pathologies: Embedded Corporatism and U.S. Drug Enforcement in the Americas
(/isis/citation/CBB525075418/)
Book
Mikkael A. Sekeres;
(2022)
Drugs and the FDA: Safety, Efficacy, and the Public's Trust
(/isis/citation/CBB614307145/)
Chapter
Daemmrich, A.;
Greene, J.;
(2010)
From Visible Harm to Relative Risk: Centralization and Fragmentation of Pharmacovigilance
(/isis/citation/CBB001221031/)
Article
Daemmrich, A.;
(2007)
Pharmaceutical Regulation in the United States and Europe
(/isis/citation/CBB001221028/)
Article
Salla Sariola;
Roger Jeffery;
Amar Jesani;
Gerard Porter;
(2019)
How Civil Society Organisations Changed the Regulation of Clinical Trials in India
(/isis/citation/CBB527783392/)
Article
João Biehl;
(2021)
The Pharmaceuticalization and Judicialization of Health: On the Interface of Medical Capitalism and Magical Legalism in Brazil
(/isis/citation/CBB223534434/)
Article
Kuo, Wen-Hua;
(2009)
The Voice on the Bridge: Taiwan's Regulatory Engagement with Global Pharmaceuticals
(/isis/citation/CBB001021062/)
Article
Christine Chambris;
Jana Visnovska;
(2022)
On the history of units in French elementary school arithmetic: The case of proportionality
(/isis/citation/CBB935801822/)
Article
Erica Torrens Rojas;
(2020)
From Darkness to Gloom: The Feminine Presence in the Teaching of Human Evolution in Mexico
(/isis/citation/CBB995188221/)
Book
Robbie Duschinsky;
Sarah Foster;
(2021)
Mentalizing and Epistemic Trust: The Work of Peter Fonagy and Colleagues at the Anna Freud Centre
(/isis/citation/CBB976066181/)
Article
Ariane d’Hoop;
(May 2021)
On the Potentialities of Spaces of Care: Openness, Enticement, and Variability in a Psychiatric Center
(/isis/citation/CBB500541512/)
Book
Beverly A. Tsacoyianis;
(2021)
Disturbing Spirits: Mental Illness, Trauma, and Treatment in Modern Syria and Lebanon
(/isis/citation/CBB488945758/)
Article
Edmund Russell;
(2022)
Presidential Address: A Coevolutionary History of COVID-19; Culture, Biology, and Mental Health
(/isis/citation/CBB065397808/)
Book
Lucas Richert;
(2014)
Conservatism, Consumer Choice, and the Food and Drug Administration During the Reagan Era: A Prescription for Scandal
(/isis/citation/CBB836915571/)
Article
Simon, Jonathan;
(2007)
The Origin of the Production of Diphtheria Antitoxin in France, between Philanthropy and Commerce
(/isis/citation/CBB000820146/)
Article
Daemmrich, Arthur;
Bowden, Mary Ellen;
(2005)
A Rising Drug Industry: Pharmaceuticals since 1870
(/isis/citation/CBB001221029/)
Book
Gaudillière, Jean-Paul;
Hess, Volker;
(2008)
Ways of Regulating: Therapeutic Agents between Plants, Shops and Consulting Rooms
(/isis/citation/CBB001221032/)
Chapter
Simon, Jonathan;
(2008)
French Serum Regulation in 1895: The Necessary Minimum or the Maximum Possible?
(/isis/citation/CBB001221038/)
Chapter
Hess, Volker;
(2008)
Secrets, Bureaucracy and the Public Drug Regulation in Prussia of the Early 19th Century
(/isis/citation/CBB001221034/)
Be the first to comment!